Exelixis
EXEL
152 hedge funds and large institutions have $1.17B invested in Exelixis in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 31 reducing their positions, and 12 closing their positions.
183% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 12
131% more call options, than puts
Call options by funds: $23.3M | Put options by funds: $10.1M
103% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 31
16% more funds holding
Funds holding: 131 → 152 (+21)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $1.44B → $1.17B (-$266M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$50M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
+$46.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.6M |
| 5 |
JP Morgan Chase
New York
|
+$8.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$138M |
| 2 |
O
OrbiMed
New York
|
-$44.3M |
| 3 |
HM
HealthCor Management
New York
|
-$21.1M |
| 4 |
Jennison Associates
New York
|
-$13.5M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.7M |
EXEL Hedge Fund Activity: Q1 2014 in Review
152 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q1 2014, worth a combined $1.17B — down 19% from $1.44B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new EXEL positions and 12 closed out — a net gain of 22 holders — while 63 added to existing stakes and 31 trimmed.
The largest buyer was Meditor Group, adding an estimated $50M. The largest seller was Capital Research Global Investors, exiting entirely with an estimated $138M sold.
- 152 institutional investors held Exelixis (EXEL) as of Q1 2014, up from 131 in Q4 2013.
- Funds reported $1.17B of Exelixis stock for Q1 2014, down 19% quarter-over-quarter.
- 34 funds opened new Exelixis positions in Q1 2014 and 12 closed out, a net change of +22 holders.
- The largest Exelixis buyer in Q1 2014 was Meditor Group, an estimated $50M added.
- The largest Exelixis seller in Q1 2014 was Capital Research Global Investors, an estimated $138M sold.
Based on aggregated 13F filings for Q1 2014.